FDA Approved Onswik for Type 2 Diabetes
The FDA has authorized the new long-acting insulin analog to help adults manage blood sugar levels.
Live Poll
Do you view the approval of new weekly insulin treatments as an improvement for patient care?
U.S. Diabetes
Recent news
September 24, 2026
Surrozen Filed FDA Application for Diabetes DrugThe company submitted an Investigational New Drug application for a new therapy to treat diabetic macular edema.
September 24, 2026
Early Transplants Improved Shwachman-Diamond SurvivalA new study found that timely hematopoietic cell transplants significantly increase life expectancy for high-risk patients.
September 23, 2026
Aaron Perry Will Launch National Health Book TourBeginning in October 2026, the two-year tour aims to improve health outcomes for Black men across 17 states.
September 22, 2026
FDA Accepted Wearable Tool for Rare Disease MeasurementThe agency approved a sensor-based metric to assess foot drop in patients with Charcot-Marie-Tooth disease type 1A.
September 22, 2026
Atacicept Slowed Kidney Decline in IgA Nephropathy StudyThe Phase 3 ORIGIN 3 trial demonstrated significant improvements in kidney function for patients treated with atacicept.
September 22, 2026
FDA Granted Priority Review to SkinTE for Diabetic UlcersThe FDA has accepted a Biologics License Application for a skin-based treatment targeting diabetic foot ulcers.
September 22, 2026
Maria Menounos Faced Health Scare From DiabetesThe 46-year-old television personality reported a medical emergency caused by complications with Type 1 diabetes.
September 21, 2026
Siemens Healthineers and Novo Partner on Liver TestsThe companies have launched a joint effort to improve diagnostic access and awareness for liver fibrosis.
September 21, 2026
FDA Approved Gene Therapy for Glycogen DisorderThe newly authorized treatment aims to restore critical glucose-releasing enzymes in patients with Type 1a disease.